Understanding PROMACTA



Adding PROMACTA® (eltrombopag) to immunosuppressive therapy has been shown to be an effective first option for patients diagnosed with severe aplastic anemia (SAA).


PROMACTA is the first and only treatment for SAA proven to boost the production of blood cells in your bone marrow.

How does PROMACTA work?

Blood Cell Production

PROMACTA is the only therapy for SAA thought to work inside the bone marrow. PROMACTA is believed to work in the stem cell together with the body’s natural process for creating new blood cells.

When your bone marrow is not producing the amount of blood cells your body needs, PROMACTA helps your body increase the production of: